NCT02677597 Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE3
NCT02665702 Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas Status UNKNOWN Phase PHASE2
NCT02658214 Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02649361 Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102) Status COMPLETED Phase PHASE2
NCT02647125 A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC Status COMPLETED Phase PHASE2
NCT02645864 Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT02606916 Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer. Status COMPLETED Phase PHASE2
NCT02586753 Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus Status UNKNOWN Phase PHASE2
NCT02465736 Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02435602 The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers Status COMPLETED Phase NA
NCT02399306 Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma Status COMPLETED Phase PHASE3
NCT02384811 Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT02350517 Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer Status COMPLETED Phase PHASE2
NCT02325986 Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT02272699 Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2/PHASE3
NCT02047305 Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia Status COMPLETED Phase NA